Carlisle Cos. (NYSE: CSL) reported Q3 EPS of $5.78, $0.05 worse than the analyst estimate of $5.83. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.38 billion.

2024 Fourth Quarter Outlook

Revenues to increase LSD

CCM - up MSD
CWT - down LSD

Adjusted EBITDA margin ~ 25%

For earnings history and earnings-related data on Carlisle Cos. (CSL) click here.